Li H. Li
- Molecular Biology
- Biotechnology top 1%
- Pharmacology top 2%
- Organic Chemistry top 5%
- Cancer Research top 5%
- Co-authors
- Kenneth L. RinehartSandra L. KuentzelPaul A. KeiferDavid G. MartinNancy L. FregeauJustin G. StrohTom G. HoltFu-Rong Sun
- Topics
- Cancer therapeutics and mechanisms (7 papers)Synthesis and Biological Activity (4 papers)Synthesis and biological activity (3 papers)
- Partner nations
- United States
In The Last Decade
Li H. Li
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 642
- Biotechnology 435
- Pharmacology 432
- Organic Chemistry 414
- Cancer Research 373
Countries citing papers authored by Li H. Li
This map shows the geographic impact of Li H. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li H. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li H. Li more than expected).
Fields of papers citing papers by Li H. Li
This network shows the impact of papers produced by Li H. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li H. Li. The network helps show where Li H. Li may publish in the future.
Co-authorship network of co-authors of Li H. Li
This figure shows the co-authorship network connecting the top 25 collaborators of Li H. Li. A scholar is included among the top collaborators of Li H. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li H. Li. Li H. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 20 | |
| 3 | 66 | |
| 4 | 98 | |
| 5 | 364 | |
| 6 | 6 | |
| 7 | Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. | 81 |
| 8 | Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia. | 29 |
| 9 | 47 | |
| 10 | 2 | |
| 11 | Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones. | 11 |
| 12 | Biochemical and cellular effects of didemnins A and B. | 63 |
| 13 | Mechanism of interaction of CC-1065 (NSC 298223) with DNA. | 93 |
| 14 | 52 | |
| 15 | Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization. | 10 |
| 16 | 16 | |
| 17 | Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia. | 52 |
| 18 | 49 | |
| 19 | 25 | |
| 20 | 25 |
About Li H. Li
Li H. Li is a scholar working on Molecular Medicine, Biotechnology and Cancer Research, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Synthesis and Biological Activity (4 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Biotechnology (435 citations), Pharmacology (432 citations) and Cancer Research (373 citations). Li H. Li has collaborated with scholars based in United States. Frequent co-authors include Kenneth L. Rinehart, Sandra L. Kuentzel, Paul A. Keifer, David G. Martin, Nancy L. Fregeau, Justin G. Stroh, Tom G. Holt, Fu-Rong Sun, William C. Krueger and J. Patrick McGovren. Their work appears in journals such as Science, Journal of the American Chemical Society and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.